Directory Calendar News Careers Alumni Giving

Faculty Research

Our Groundbreaking Research

Department of Infectious Diseases and Microbiology (IDM) faculty members have been awarded more than $150 million in funding from the National Institutes of Health (NIH) and other agencies over the past 10 years. Since 2003, Pitt Public Health has consistently ranked third nationally in NIH funding among comparable institutions. Our research involves students, postdoctoral fellows, and highly trained support staff.
The following are examples of standout funded IDM faculty research.

HIV and Development of HIV Vaccines and Immunotherapies

Pitt Public Health has received a five-year, $7.2 million grant from the National Institute of Allergy and Infectious Diseases to develop microbicides against HIV transmission. Microbicides are substances designed to prevent or reduce the sexual transmission of HIV when applied topically to the vagina or rectum. The grant will allow researchers to test two formulations—a film and ring—that release the active ingredient over time. They will likely have to test many products before finding one that is safe and effective against HIV as well as easy to use and acceptable to both sexual partners. “The HIV/AIDS epidemic remains uncontrolled in many regions in the world,” said principal investigator Phalguni Gupta, Professor and Assistant IDM Chair. “In developing countries, HIV is most often spread through unprotected heterosexual intercourse, creating a great need for new ways to prevent transmission beyond the condom whose use is often at the discretion of men.” They also plan to test the microbicides in the presence of other sexually transmitted diseases and bacterial vaginosis, a common vaginal infection.


Complications of Antiretroviral Therapy

Assistant Professor Jeremy Martinson is leading research on genetic factors affecting cardiovascular complications of HIV therapy. The introduction of Highly Active Antiretroviral Therapy (HAART) has transformed the lives of many HIV-positive individuals. For some, however, HAART carries a risk of cardiovascular side effects, although the etiology of this is unknown. HIV infection is known to contribute to cardiovascular disease risk in some patients. Martinson and his team are investigating the extent to which host genetics, HIV infection, and treatment with HAART interact to give rise to cardiovascular disease in patients enrolled in the Multicenter AIDS Cohort Study. They are currently using a variety of high-throughput genomic and transcriptomic approaches to study this phenomenon.


AIDS Education and Prevention

“Disparities in health care, the stigma of HIV/AIDS, and the need for more timely testing and treatment are still barriers to delivering and improving HIV care,” said Linda Frank, Associate Professor. Frank is a principal investigator at the Pennsylvania/MidAtlantic AIDS Education and Training Center, headquartered at Pitt Public Health since 1988. The center is a national leader in supporting the training and education of health professionals who care for the thousands of people infected annually with HIV in the United States. A recent grant will allow scientists like Frank to continue to provide critical training to health professionals to reduce barriers to HIV care, increase HIV testing, integrate HIV prevention into primary care, and improve linkages to HIV treatment and expert clinical management of HIV and other comorbid conditions, such as hepatitis, sexually transmitted infections, tuberculosis, and substance use.


Herpesviruses

Recent studies in the laboratory of Assistant Professor, Giovanna Rappocciolo, have identified DC-SIGN and langerin, two C-type lectins, as the main receptor used by human herpesvirus 8 (HHV-8), or KSHV, the cause of Kaposi's sarcoma, to infect dendritic cells, dermal dendritic cells, B lymphocytes and macrophages. These findings established the first in vitro model of productive HHV8 infection of its natural target cells. 

Slide1636603637184673881

HIV-1 Immunopathology

Recent studies in the laboratory of Assistant Professor, Giovanna Rappocciolo have identified dysregulation of cholesterol metabolism pathways in antigen presenting cells as regulator of HIV-1 disease progression in the absence of antiretroviral therapies.  Recent studies are now identifying signaling metabolites and specific miRNAs as modulators of cholesterol metabolic pathways in individuals naturally able to control HIV-1 disease progression.

Tuberculosis

Nearly one third of the world’s population is infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB). Although the vast majority of M. tuberculosis-infected people never experience the clinical symptoms of TB, there are almost 11 million new cases of TB and two million TB-related deaths annually. HIV is strongly associated with active TB, even in individuals with well-preserved CD4+ T cell levels, and TB is the leading cause of death in HIV-infected individuals. The causes of active TB are poorly understood, but are likely to include changes in anti-mycobacterial immune responses in granulomas, the site of M. tuberculosis infection. Assistant Professor, Josh Mattila and his lab are focused on understanding the immune environment in lungs and TB granulomas. His particular interest is examining interactions between myeloid cells, including macrophages and neutrophils, and T cells in this environment with the objective of identifying factors that differentiate pathologic and protective responses.

Josh image636547349271307145

T cells (red) and macrophages (green) are present in distinct regions in granulomas where they cooperate to control Mycobacterium tuberculosis infection.






EMERGING INFECTIONS

Influenza virus is a respiratory pathogen that targets the lung, and innate immune responses serve a key role in providing early antiviral immunity and limiting disease in acute infection. However, the relationship between dendritic cells and immunity in the lung is not well defined. Professor Simon M. Barratt-Boyes and his team have used the murine model to examine the impact of plasmacytoid dendritic cells in the early immune response to influenza virus infection. They are also studying the dynamics of the dendritic cell response to avian influenza virus infection in the lung of nonhuman primates, which they believe serves as a more robust model of influenza in humans than do mice.


HIV-1 Associated Neuropathogenesis and Biomarker Discovery

HIV-associated neurocognitive impairment (HAND) is commonly observed in AIDS patients worldwide. During early infection, HIV-1 enters the Central Nervous System (CNS) and resides in macrophages/microglia and causes neuronal degeneration and inflammation in the brain. HAART therapy has improved the quality of life and longevity of HIV-1 infected patients; however, with aging, the prevalence of HAND is high in this population. Velpandi Ayyavoo’s laboratory focuses on understanding how HIV-1 induces neuronal dysfunction and destruction and how to detect them during the early stages as neurodegeneration occurs over a long period of time resulting in clinical manifestations. Her team uses several genomic and proteomic approaches to develop early biomarkers to detect HAND. Additionally, results from this study will help to identify novel targets and to design new therapeutics against HIV-1 in the central nervous system.

Recent IDM Publications

Development of antibody biomarkers of long term and recent dengue virus infections 

Development of antibody biomarkers of long term and recent dengue virus infections

JOURNAL OF VIROLOGICAL METHODS - BURKE, MARQUES, and colleagues discuss anti-dengue NS1-specific IgG and IgG3 as potential biomarkers of long-term and recent (less than 6 months) DENV infections, respectively.  (06/14/2018)

Tradition and innovation in development of a Zika vaccine 

Tradition and innovation in development of a Zika vaccine

THE LANCET - MARQUES and BURKE comment about two Zika vaccines in clinical development and describe the challenges ahead. (06/14/2018)

Zika virus displacement by a chikungunya outbreak in Recife, Brazil 

Zika virus displacement by a chikungunya outbreak in Recife, Brazil

PUBLIC LIBRARY OF SCIENCE - Magalhaes, Braga, Cordeiro, Oliveira, Castanha, Maciel, Amancio, Gouveia, Peixoto-deSilva Jr., Peixoto, Britto, Lima, Lima, and Marques detected the tail end of a Zika epidemic in 2015-16 which was displaced by a chikungunya epidemic. Few dengue cases were identified des... (06/14/2018)

Rift Valley fever in animals and humans: Current perspectives 

Rift Valley fever in animals and humans: Current perspectives

ANTIVIRAL RESEARCH - McMillen and Hartman discuss the historical role of Rift Valley Fever (RVF) as a biological weapon and conclude with an outline of the important unanswered questions for ongoing research into this important zoonotic disease. (06/11/2018)

Inefficient HIV-1 trans infection of CD4+ T cells by macrophages from HIV-1 nonprogressors is associated with altered membrane cholesterol and DC-SIGN 

Inefficient HIV-1 trans infection of CD4+ T cells by macrophages from HIV-1 nonprogressors is associated with altered membrane cholesterol and DC-SIGN

JOURNAL OF VIROLOGY - Delucia, Rinaldo, Rappocciolo demonstrate that the use of SIMV to decrease macrophage-mediated virus transfer should be considered for future HIV therapeutic development.  (05/18/2018)

Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysredulates neurogranin and induces synaptodendritic injury 

Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysredulates neurogranin and induces synaptodendritic injury

JOURNAL OF NEUROINFLAMMATION - Guha, Wagner, Ayyavoo conduct first study evaluating the potential role of Ng in the context of HIV-1 neropathogens and conclude that synaptic damage in HAND+ patients could be a result of abrogation of Ng through HIV-1 induced inflammation that dysregulates Ng-CaM in... (05/18/2018)

Widespread virus replication in alveoli drives acute respiratory distress syndrome in aerosolized H5N1 influenza infection of macaques 

Widespread virus replication in alveoli drives acute respiratory distress syndrome in aerosolized H5N1 influenza infection of macaques

JOURNAL OF IMMUNOLOGY - Wonderlich, Swan, Bissel, Hartman, Carney, O'Malley, Obadan, Santos, Walker, Sturgeon, Frye, Maiello, Scanga, Bowling, Duangkhae, Wiley, Flynn, Wang, Cole, Reed, Barratt-Boyes establish a new nonhuman primate disease model for evaluation of vaccine and therapeutic approaches... (02/14/2018)

Novel assay reveals a large inducible replication competent HIV-1 reservoir in resting CD4+ T cells 

Novel assay reveals a large inducible replication competent HIV-1 reservoir in resting CD4+ T cells

NATURE MEDICINE - Gupta, Sanyal, Ratner, Ding, Zerbato, Giacobbi, Venkatachari, Patterson, Chargin, Chen, Mailliard, Rinaldo, and Sluis-Cremer found that the size of the inducible latent HIV-1 reservoir in aviremic subjects on ART is approximately 70-fold larger than previous estimates.  (02/08/2018)

Share Your News

Share stories about Pitt Public Health students, researchers, faculty, or staff using the form at publichealth.pitt.edu/sharenews.

Or, forward information to phcomm@pitt.edu.

IDM Research Videos

image

IDM’s Rinaldo discusses HIV wonder drugs and curing HIV in 1998 World AIDS Day interview (VIDEO) 

IDM’s Rinaldo discusses HIV wonder drugs and curing HIV in 1998 World AIDS Day interview (VIDEO)

UPMC HEALTH NEWS – In the late 1990s, new and highly potent anti-HIV drugs emerged— including protease and reverse transcriptase inhibitors—which could for the first time control HIV infection. For this 1998 World AIDS Day, Pitt IDM AIDS researcher Charles Rinaldo and the late Bridget Murtagh of th... (07/17/2018)
image

Mailliard presents research on improving HIV “kick and kill” strategies to IAS Conference on HIV Science in Paris (Video) 

Mailliard presents research on improving HIV “kick and kill” strategies to IAS Conference on HIV Science in Paris (Video)

YOUTUBE - IDM's Mailliard presents his research on “kick and kill” strategies at the 9th IAS Conference on HIV Science, the world's largest open scientific conference on HIV and AIDS-related issues. The work demonstrates that naïve T cells have the ability to effectively target the HIV-1 reservoir,... (11/07/2017)
image

Discussing the legacy of polio, one of the most dreaded disease in history (VIDEO) 

Discussing the legacy of polio, one of the most dreaded disease in history (VIDEO)

KD/PG SUNDAY EDITION - KDKA’s Stacy Smith and the Post-Gazette’s Jerry Micco discuss present-day challenges in the worldwide fight to eradicate polio with PETER SALK, visiting professor  in IDM, as well as his childhood growing up in Pittsburgh while his father's team developed the first injectable... (09/20/2017)
image

Frank on Telehealth Appalachian AIDS Education and Training (video) 

Frank on Telehealth Appalachian AIDS Education and Training (video)

The Telehealth Appalachian AIDS Education and Training Center Project, led by IDM's LINDA FRANK, provides web-based HIV education, training, clinical guidelines, and resources to Appalachian community health centers. Frank has worked to increase knowledge and awareness about HIV disease in underser... (09/19/2017)
View more IDM research & faculty news
© 2018 by University of Pittsburgh Graduate School of Public Health

Login  |  Sitemap